GNS Healthcare applies its groundbreaking, powerful artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.
We work with leading biopharma companies to accelerate and optimize drug discovery, development and commercialization. Our platform leverages both clinical trial data and real world data (RWD) to model patient response to treatment in silico. These insights enable biopharma to discover which subpopulations of patients respond, which do not and more importantly understand why, directly from the data and without bias. These models can also be used to conduct in silico clinical trials generating real world evidence of a drug’s value in the real world, both before and after launch.
We partner with innovative health plans to identify which members will respond to which drug and care management interventions at what point in time. Our platform provides a prescriptive approach allowing health plans to understand the effectiveness of specific interventions, member by member.
We work with progressive patient foundations to discover novel disease pathways and drug targets to accelerate the development of new therapeutics.
By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals to dramatically improve health outcomes and reduce the total cost of care.
We understand that in order to make precision medicine a reality, we need to discover and deliver novel insights that will cure disease and heal the healthcare system.
OUR AI PLATFORM: REFS™
REFS (Reverse Engineering Forward Simulation) uncovers the cause and effect relationships from data at scale to solve healthcare’s matching problem and make precision medicine a reality.
Speed to discovery
Our platform works by reconstructing complex diseases into computer models which allows users to simulate real world scenarios that take the guesswork out of critical decisions and increase the speed to discovery from years to months.
Transparency of results
By employing causal machine learning, our models not only deliver novel insights, they identify the underlying cause and effect relationships, crucial to understanding and treating the root cause of disease progression and patient response.
Unlimited data volume and variety
We transform and integrate millions of data points of all types – EMR, genetic, proteomic, genomic, claims, consumer, laboratory, prescription, mobile health, sociodemographic and more – revealing unforeseen relationships in a dynamic platform that continues to grow smarter over time.
Healthcare’s Most Powerful AI Solution
Understand the power of causal machine learning, why it’s different than other AI solutions and why it’s critical to transform biomedicine and healthcare. Check out video below to learn more.
GNS By The Numbers
We’re all about data points, numbers and evidence.
Complex Models Built
Data Points Modeled
Years Applying AI to Healthcare
Diseases Modeled
Peer Reviewed Journal Articles & Posters
Our Clients
Our Blog
-
Answering the Elusive “Why” is Possible in Healthcare…If You Use the Right Type of AI
by news@gnshealthcare.com (GNS Healthcare) on November 15, 2018 at 2:00 pm
Between 2006 and 2016 there were over 2 million scholarly articles published around the globe. Of those, more than 25 percent – 568,000 – […]
-
Immunotherapy and AI: Advancing Our View of Cancer Treatment
by news@gnshealthcare.com (GNS Healthcare) on November 8, 2018 at 2:07 pm
Most allergy sufferers know that receiving a series of allergy shots can prevent sniffling, sneezing, and red eyes. But not everyone is aware of how […]
-
Democratizing Data: How Visualization is Expanding Data's Impact
by news@gnshealthcare.com (GNS Healthcare) on November 1, 2018 at 2:16 pm
Striving to effectively communicate thoughts and ideas has been an aim of humans since the dawn of time. The Cro-Magnons used charcoal to scrawl […]
News & Events
GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read moreGNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018
CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...
read moreFeatured Content
Improving The Probability of Success: New Tools in Drug Development
How robust data and powerful AI is changing the way drugs are developed.
Why BioPharma Needs AI to Succeed
Check out our infographic to see why biopharma needs AI to succeed.